Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thromb…
Medical - Devices
US, Alameda [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 1.03 | 6.12 | 6.06 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -79.90 | 0.42 | 2.11 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 1.85 | 31.09 | 30.52 | |
| Cash | 8.15 | 8.10 | 7.49 | |
| Capex | -59.41 | -0.15 | -0.09 | |
| Free Cash Flow | -0.67 | 0.84 | 0.84 | |
| Revenue | -2.34 | 7.20 | 7.37 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -2.39 | 0.64 | 0.66 | |
| Operating Margin | -64.71 | 0.04 | 0.12 | |
| ROA | -80.01 | < 0.005 | 0.03 | |
| ROE | -80.12 | < 0.005 | 0.05 | |
| ROIC | -81.99 | < 0.005 | 0.04 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of PEN is permitted for members.
5
Growth
The "Growth Entry" for the Focus of PEN is permitted for members.
6
Leverage & Liquidity